H.A.M. van Muilekom

The Netherlands Cancer Institute

Papers

3

Total Citations

35

H-Index

3

About

H.A.M. van Muilekom is a clinical researcher whose work centers on improving functional outcomes for men undergoing prostate cancer surgery, particularly robot-assisted laparoscopic radical prostatectomy (RARP). His primary research areas include urinary incontinence prediction, surgical technique refinement, and patient-centered decision-making. Van Muilekom’s most impactful contribution is a 2021 study on individual risk prediction for post-prostatectomy incontinence, which demonstrated how personalized risk assessments can influence treatment choice and support shared decision-making—a paper that has garnered 18 citations. He has also advanced surgical practice through investigations of vesico-urethral anastomosis evaluation, using selective cystograms to improve short- and long-term continence outcomes (14 citations). Additionally, his earlier work on vas deferens urethral support techniques provided foundational insights into early post-operative urine continence. By bridging predictive analytics with surgical innovation, van Muilekom’s research directly enhances quality of life for prostate cancer patients, offering clinicians evidence-based tools to tailor care and reduce the burden of treatment-related side effects.

Research Focus

Key Achievements

3
H-Index
3
Papers
35
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Individual risk prediction of urinary incontinence after prostatectomy and impact on treatment choice in patients with localized prostate cancer
18 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: The Netherlands Cancer Institute

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago